ORNA THERAPEUTICS

orna-therapeutics-logo

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Event #Website #More

ORNA THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical Therapeutics

Founded:
2019-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.ornatx.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
321 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Sitelinks Search Box


Similar Organizations

abata-therapeutics-logo

Abata Therapeutics

Abata Therapeutics is a biotech company.

axcella-logo

Axcella

Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.

bio-detection-k9-logo

Bio-Detection K9

Bio-Detection K9 is a biotech company specialized in the canine detection of bacteria and viruses particular of covid-19.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

starton-therapeutics-logo

Starton Therapeutics

Starton Therapeutics is a biotechnology company that focuses on transforming standard of care in therapeutics.

kymera-therapeutics-logo

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

theracea-pharma-logo

TheraCea Pharma

TheraCea Pharma is a biotechnology company that develops precision medicine to help people with neurological disorders.

Current Employees Featured

alex-wesselhoeft_image

Alex Wesselhoeft
Alex Wesselhoeft Founder & Director, Molecular Biology @ Orna Therapeutics
Founder & Director, Molecular Biology
2019-07-01

raffaella-squilloni_image

Raffaella Squilloni
Raffaella Squilloni Founder, Director of Business Development & Former Board Director @ Orna Therapeutics
Founder, Director of Business Development & Former Board Director
2018-01-01

thomas-m-barnes_image

Thomas M. Barnes
Thomas M. Barnes Chief Executive Officer @ Orna Therapeutics
Chief Executive Officer

daniel-anderson_image

Daniel Anderson
Daniel Anderson Founder @ Orna Therapeutics
Founder

nishla-keiser_image

Nishla Keiser
Nishla Keiser Chief Legal and Strategy Officer @ Orna Therapeutics
Chief Legal and Strategy Officer
2021-01-01

john-mccabe_image

John McCabe
John McCabe Chief Financial Officer @ Orna Therapeutics
Chief Financial Officer
2020-08-01

Founder


alex-wesselhoeft_image

Alex Wesselhoeft

daniel-anderson_image

Daniel Anderson

raffaella-squilloni_image

Raffaella Squilloni

Investors List

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Orna Therapeutics

bioimpact_image

BioImpact

BioImpact investment in Series B - Orna Therapeutics

merck-kgaa_image

Merck

Merck investment in Series B - Orna Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Orna Therapeutics

the-pags-group_image

The Pags Group

The Pags Group investment in Series A - Orna Therapeutics

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series A - Orna Therapeutics

f2-ventures_image

F2 Ventures

F2 Ventures investment in Series A - Orna Therapeutics

taiho-ventures-2_image

Taiho Ventures

Taiho Ventures investment in Series A - Orna Therapeutics

bristol-myers-squibb_image

Bristol Myers Squibb

Bristol Myers Squibb investment in Series A - Orna Therapeutics

novartis-institutes-for-biomedical-research_image

Novartis Institutes for Biomedical Research

Novartis Institutes for Biomedical Research investment in Series A - Orna Therapeutics

Key Employee Changes

Date New article
2021-12-16 Orna Therapeutics Expands Leadership Team with Key Executive Hires

Official Site Inspections

http://www.ornatx.com Semrush global rank: 5.07 M Semrush visits lastest month: 1.62 K

  • Host name: 141.193.213.10
  • IP address: 141.193.213.10
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Orna Therapeutics"

About Us - Orna Therapeutics

Our team has the experience to take our comprehensive oRNA ® and LNP platform โ€ฆSee details»

Orna Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular โ€ฆSee details»

Orna Therapeutics - LinkedIn

Orna Therapeutics is a biotechnology company reshaping RNA therapeutics. We are developing the leading circular RNA technology platform (oRNA®) and unprecedented lipid nanoparticle (LNP) delivery ...See details»

Orna Therapeutics - Overview, News & Similar companies

May 22, 2024 Orna Therapeutics contact info: Phone number: (617) 977-6357 Website: โ€ฆSee details»

Careers - Orna Therapeutics

Please note that Orna partners with select organizations to recruit talent. To avoid scams targeting our candidates, correspondence from our recruiting team will only come from [email protected] or other @ornatx.com addresses. Our โ€ฆSee details»

Orna Therapeutics CEO and key executive team - Craft.co

Orna Therapeutics's Chief Executive Officer is Thomas Barnes. Other executives include John โ€ฆSee details»

Orna Therapeutics - VentureRadar

"Orna Therapeutics is an MIT spin-off developing fully engineered circular RNA (oRNA) โ€ฆSee details»

Merck and Orna Therapeutics Collaborate to Advance Ornaโ€™s Next ...

Aug 16, 2022 Contacts. Merck Media: Melissa Moody (215) 407-3536 Justine Moore (908) โ€ฆSee details»

Merck and Orna Therapeutics Collaborate to Advance Ornaโ€™s Next ...

Aug 16, 2022 To learn more visit: www.ornatx.com and follow Orna Therapeutics on Twitter โ€ฆSee details»

Orna Therapeutics Announces Strategic Acquisition of โ€ฆ

May 23, 2024 To learn more, visit www.ornatx.com and follow Orna Therapeutics on X and LinkedIn. About ReNAgade Therapeutics ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere ...See details»

Orna Therapeutics Launches with over $100M Raised to Develop a โ€ฆ

Www.ornatx.com and follow Orna Therapeutics on Twitter and LinkedIn. About MPM Capital โ€ฆSee details»

Orna Therapeutics Launches with over $100M Raised to Develop a โ€ฆ

CAMBRIDGE, Mass., Feb. 24, 2021 /PRNewswire/ -- Orna Therapeutics, a biotechnology โ€ฆSee details»

Orna - Company Profile - Tracxn

Aug 17, 2021 Orna ranks 2nd among 43 active competitors. 16 of its competitors are funded โ€ฆSee details»

Orna Therapeutics: Culture | LinkedIn

Website: www.ornatx.com. Orna Therapeutics | 20,477 followers on LinkedIn. Ahead of the โ€ฆSee details»

Orna Therapeutics Announces Strategic Acquisition of ReNAgade ...

May 23, 2024 Orna Therapeutics, a biotechnology company dedicated to designing and โ€ฆSee details»

Our Approach & Strategy - Orna Therapeutics

Each segment of the oRNA ® sequence is designed for a specific effect: driving circularization, โ€ฆSee details»

Orna Therapeutics Unveils Progress of Circular RNA Platform and ...

May 18, 2023 /PRNewswire/ -- Orna Therapeutics, a biotechnology company pioneering a โ€ฆSee details»

Our Pipeline - Orna Therapeutics

Ornaโ€™s in vivo CAR platform (panCARโ„ข) combines oRNA ® technology with our proprietary โ€ฆSee details»

News & Media - Orna Therapeutics

Latest news will be published here.See details»

linkstock.net © 2022. All rights reserved